Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Treatment

Patients Deserve Investment In Future Doctors, Says British Medical Association Northern Ireland
Medical students and teaching staff have welcomed the Review & Modernisation of Supplement for Undergraduate Medical and Dental Education (SUMDE) consultation, which was undertaken by the DHSSPS.
generic viagra online
Discovery May Revolutionize Therapy In Muscular Dystrophy And Other Skeletal Muscle Disorders
Researchers at UMDNJ-Robert Wood Johnson Medical School are a step closer to treating, and perhaps preventing, muscle damage caused by disease and aging. In their study, published in the June issue of Journal of Biological Chemistry, the scientists have linked the newly discovered protein MG53 to a pathway that repairs human muscle tissue along with the proteins caveolin-3 (Cav3) and dysferlin. Prior to this study, the underlying interactions that inhibited membrane repair in muscle tissue were unknown. Linking these proteins creates a mechanism that allows damaged membranes to be repaired, which may transform treatment for patients who suffer from severe complications of diseases such as muscular dystrophy, as well as cardiovascular disorders and conditions related to advancing age.
News of the day
HANYS Presents Its Top Honor, The Distinguished Service Award, To New York State's Health Care Auxilians
Hundreds of health care leaders from throughout the state gathered Wednesday evening in Lake George as the Healthcare Association of New York State (HANYS) presented its 30th annual Distinguished Service Award, its highest honor, to New York State"s health care auxiliaries. Since 1979, HANYS has awarded the Distinguished Service Award to individuals who demonstrate their extraordinary commitment to improving health care through service to their community.
Cardiovascular

New York Times Examines Pilot Program To Fight Drug-Resistant TB In South African Communities

The New York Times examines a Doctors Without Borders pilot program to fight drug-resistant tuberculosis in South Africa that allows patients to stay in their homes rather than be isolated in hospital during treatment. The program, which is supported by the city of Cape Town and the Western Cape Province, aims to "show that such patients can be successfully treated in an impoverished community ò€¦ even while they are still infectious," the New York Times writes. Cheryl McDermid, a Canadian doctor with Doctors Without Borders, manages the program in the town of Khayelitsha. "About a fifth of the patients enrolled last year died, either while waiting weeks for a diagnosis or after treatment began. One in six of those who started treatment dropped out. But most patients have stuck with it and are now no longer infectious," the newspaper writes. McDermid said although it is still too early to know what the treatment success rate will be, there is no evidence that patients in the program are infecting the people who live with them. "Drug-resistant tuberculosis is a mounting global health threat," according to the newspaper. The disease is a "particularly virulent problem in Africa, where AIDS has heightened the vulnerability of millions," the New York Times writes. According to Paul Nunn, coordinator of the drug-resistance unit in the WHO"s TB department, ten African countries do not even have laboratories that can detect drug-resistant TB (Dugger, 7/28). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009